Amgen (Q14171): Difference between revisions
Jump to navigation
Jump to search
Created claim: legal form (P28): public company (Q8826) |
Created claim: stock exchange (P574): Nasdaq (Q8874) |
||||||||||||||
Property / stock exchange | |||||||||||||||
Property / stock exchange: Nasdaq / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / stock exchange: Nasdaq / qualifier | |||||||||||||||
ticker symbol: AMGN | |||||||||||||||
Property / stock exchange: Nasdaq / qualifier | |||||||||||||||
start time: 2 January 1990
|
Revision as of 07:29, 15 August 2023
American multinational biopharmaceutical company
- Applied Molecular Genetics
- Amgen Inc.
Language | Label | Description | Also known as |
---|---|---|---|
English | Amgen |
American multinational biopharmaceutical company |
|
Statements
1980
0 references